Lipid peroxidation and plasma vitamin E concentration in hypercholesterolemic children from Medellin (Colombia);Peroxidación lipídica y concentración de vitamina E plasmática en niños hipercolesterolémicos de Medellín (Colombia)

Anales de Pediatria

Volumn 61, Issue 1, 2004, Pages 16-22

  Velasquez Rodriguez C M ^a   Uscategui Penuela R M ^a   Burgos Herrera, L C ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Children; Hypercholesterolemia; LDL; Lipid peroxidation; Malondialdehyde; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COLOMBIA; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SCHOOL CHILD; VITAMIN BLOOD LEVEL;

EID: 3543114276     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13063999     Document Type: Article

References (37)

1. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998;78:547-81.
2. Wanders RJ, Vreken P, Ferdinandusse S, Jansen GA, Waterham HR, Van Roermund CW, et al. Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans 2001;29:250-67.
3. Schwenke DC. Antioxidants and Atherogenesis. J Nutr Biochem 1998;9:424-45.
4. Quyyumi AA. Endothelial function in health and disease: New insights into the genesis of cardiovascular disease. Am J Med 1998;105:32S-39S.
5. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-6.
6. McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med 1999;26:1034-53.
7. Stocker R. The ambivalence of vitamin E in atherogenesis. Trends Biochem Sci 1999;24:219-23.
8. Colombia. Ministerio de Salud, OPS, OMS. Situación de Salud de Colombia. Indicadores Básicos 2001. 1-15. Disponible en: www.minasulud.gov.co. Consultado en marzo de 2002.
9. Uscátegui Peñuela RM, Álvarez Uribe MC, Laguado Salinas I, Soler Terranova W, Martínez Maluendas L, Arias Arteaga R, et al. Cardiovascular risk factors in children and teenagers aged 6-18 years old from Medellin (Colombia). An Pediatr 2003;58:411-7.
10. Chirico S. High-performance liquid chromatography-Based thiobarbituric acid test. Methods Enzymol 1994;233:314-8.
11. NCEP. Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:531-37.
12. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-95.
13. Nagele U, Hageie OE, Sauer G, Wiedemann E, Lehmann P, Wahlefeid AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 1984;22:165-74.
14. Gennaio E. Cholesterol reference method laboratory network. Boehringer Mannheim System, 1997.
15. Fridewald WT, Levin RY, Fredrickson DS. Estimations of the concentration of c-LDL in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-507.
16. Hoehler D, Frohlich AA, Marquardt RR, Stelsovsky H. Extraction of alfa tocopherol from serum prior reversed-phase liquid chromatogaraphy. J Agric Food Chem 1998;46:973-8.
17. National Center for Health Statistics N. Growth curves for children birth-18 years. U.S. Department of Health, Education and Welfare, 1977.
18. Must A, Dallal GE, Dietz WH. Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Am J Clin Nutr 1991;53:839-46.
19. Crossley SJ. Joint FAO/WHO Geneva consultation-acute dietary intake methodology. Food Addit Contam 2000;17:557-62.
20. Groff J. Vitamin E. En: Groff JL, Gropper SS, Hunt SM, editors. Advanced nutrition and human metabolim. New York: West Publishing Company, 1995; p. 306-12.
21. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997;43:1209-14.
22. Bonithon-Kopp C, Coudray C, Berr C, Touboul PJ, Feve JM, Favier A, et al. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Arteriel. Am J Clin Nutr 1997;65:121-7.
23. Konukoglu D, Akcay T, Erdem T. Susceptibility of erythrocyte lipids to oxidation and erythrocyte antioxidant status in myocardial infarction. Clin Biochem 1998;31:667-71.
24. Dincer Y, Akcay T, Konukoglu D, Hatemi H. Erythrocyte susceptibility to lipid peroxidation in patients with coronary atherosclerosis. Acta Med Okayama 1999;53:259-64.
25. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 2001;53:33-9.
26. Saygili EI, Konukoglu D, Papila C, Akcay T. Levels of plasma vitamin E, vitamin C, TBARS, and cholesterol in male patients with colorectal tumors. Biochemistry (Mosc) 2003;68:325-8.
27. Davi G, Alessandrini P, Mezzetti A, Minotti G, Bucciarelli T, Costantini F, et al. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1997;17:3230-5.
28. Reilly MP, Pratico D, Delanty N. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation 1998;98:2822-8.
29. Cracowski JL, Ploin D, Bessard J, Baguet JP, Stanke-Labesque F, Mallion JM, et al. Formation of isoprostanes in children with type IIa hypercholesterolemia. J Cardiovasc Pharmacol 2001;38:228-31.
30. Muldoon MF, Kritchevsky SB, Evans RW, Kagan VE. Serum total antioxidant activity in relative hypo- and hypercholesterolemia. Free Radic Res 1996;25:239-45.
31. Van Lente F, Daher R, Waletzky JA. Vitamin E compared with other potential risk factor concentrations in patients with and without coronary artery disease: A case-matched study. Eur J Clin Chem Clin Biochem 1994;32:583-7.
32. Simon E, Paul JL, Soni T, Simon A, Moatti N. Plasma and erythrocyte vitamin E content in asymptomatic hypercholesterolemic subjects. Clin Chem 1997;43:285-9.
33. Schwenke DC. Antioxidants, dietary fat saturation, lipoprotein oxidation and atherogenesis. Nutrition 1996;12:377-9.
34. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H. Vitamin E deficiency in variant angina. Circulation 1996;94:14-8.
35. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag MJ. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 1994;90:1154-61.
36. Pryor WA. Vitamin E and heart disease: Basic science to clinical intervention trials. Free Radic Biol Med 2000;28:141-64.
37. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53:326S-334S.